(142) Understanding Risk Factors for Stroke Subtypes in the ENDURANCE TrialsSung-Min Cho, MD
(143) Long-Term Burden of Hemocompatibility Related Adverse Events in the MOMENTUM 3 Trial: Final Analysis of the 1028 Patient CohortNir Uriel, MD
(144) Two-Year Outcomes in Real World Patients Treated with Heartmate 3TM Left Ventricular Assist Device for Advanced Heart Failure: Data from the ELEVATE RegistryDiyar Saeed, MD, PhD
(145) Impact of Stroke Onset Severity on 2-Year Survival in Destination Therapy Patients Supported by Centrifugal Flow versus Axial Flow Ventricular Assist DevicesPalak Shah, MD
(146) Apixaban in HVAD Patients Non-Compliant to Standard Vitamin-K-AntagonismSebastian Schulte-Eistrup, MD, PhD
(147) Presence of Left Atrial or Left Ventricular Thrombus at the Time of CF-LVAD Implantation is Associated with Increased Post-Operative Risk of Stroke or DeathJustin Fried, MD
(148) Occurrence and Clinical Patterns of Stroke Based on Arterial Cannulation Strategy during Veno-Arterial Extracorporeal Membrane Oxygenation SupportMia Nishikawa, B.A.
You must be logged in and own this session in order to